Molecular Partners AG

MOLN NASDAQ Santé & Biotech Europe US60853G1067
3.92 $
1.82 %

Entreprise biopharmaceutique suisse développant des médicaments thérapeutiques innovants basés sur des protéines DARPin pour le traitement du cancer et d'autres maladies.

Performance & Momentum

6 Months 7.89 %
1 Year 0.26 %
3 Years 43.24 %
5 Years 80.01 %

Similar stocks to Molecular Partners AG

Anantys Community

Be the first to share your analysis on Molecular Partners AG.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases